Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma (Q34268395)

1 August 2017

title

Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma (English)

1 reference

1 August 2017

main subject

protein ubiquitination

1 reference

Jens U Marquardt

7

1 reference

ORCID Public Data File 2021

author name string

Yun-Han Lee

1

1 reference

1 August 2017

Jesper B Andersen

2

1 reference

1 August 2017

Ho-Taek Song

3

1 reference

1 August 2017

Adam D Judge

4

1 reference

1 August 2017

Daekwan Seo

5

1 reference

1 August 2017

Tsuyoshi Ishikawa

6

1 reference

1 August 2017

Mitsuteru Kitade

8

1 reference

1 August 2017

Marian E Durkin

9

1 reference

1 August 2017

Chiara Raggi

10

1 reference

1 August 2017

Hyun Goo Woo

11

1 reference

1 August 2017

Elizabeth A Conner

12

1 reference

1 August 2017

Itzhak Avital

13

1 reference

1 August 2017

Ian Maclachlan

14

1 reference

1 August 2017

Valentina M Factor

15

1 reference

1 August 2017

Snorri S Thorgeirsson

16

1 reference

1 August 2017

language of work or name

English

0 references

publication date

19 October 2010

1 reference

1 August 2017

1 reference

1 August 2017

volume

70

1 reference

1 August 2017

issue

21

1 reference

1 August 2017

page(s)

8264-8269

1 reference

Mammalian COP9 signalosome

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Molecular targeted therapies in hepatocellular carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Sorafenib in advanced hepatocellular carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Transcription regulation by mutant p53.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Hepatocellular carcinoma pathogenesis: from genes to environment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Management of hepatocellular carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Hepatocellular carcinoma: molecular pathways and new therapeutic targets.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Global cancer statistics, 2002

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

The ubiquitin ligase COP1 is a critical negative regulator of p53

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Genetic mechanisms of hepatocarcinogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

RNAi-mediated gene silencing in non-human primates.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970744

Molecular pathogenesis of human hepatocellular carcinoma

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20986391

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-10-0749

1 reference

1 August 2017

1 reference

1 August 2017

1 reference